Reuter James Wealth Management »

Summit Therapeutics shares owned by Reuter James Wealth Management

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Reuter James Wealth Management from 13F filings

Historical chart of Reuter James Wealth Management investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Reuter James Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Reuter James Wealth Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.8k 312 21.90

More positions owned by Reuter James Wealth Management

Wal-Mart Stores (WMT)
Ishares Gold Tr Ishares New (IAU)
Exxon Mobil Corporation (XOM)
Energy Transfer Com Ut Ltd Ptn (ET)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Invesco Exch Traded Fd Tr Ii S&p500 Hdl Vol (SPHD)
Apple (AAPL)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Listed Fd Tr Horizon Kinetics (INFL)
Alps Etf Tr Alerian Mlp (AMLP)
Union Pacific Corporation (UNP)
Spdr Gold Tr Gold Shs (GLD)
Select Sector Spdr Tr Energy (XLE)
Arthur J. Gallagher & Co. (AJG)

View all positions for Reuter James Wealth Management

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
BlackRock
FMR
T. Rowe Price Associates
State Street Corporation
Geode Capital Management
Millennium Management
Twin Tree Management
Charles Schwab Investment Management
Standard Life Aberdeen
UBS Group
Rock Springs Capital Management
Jane Street
Goldman Sachs Group

View all funds holding Summit Therapeutics